Ligand Pharmaceuticals Inc (LGND)
86.01
+0.99
(+1.16%)
USD |
NASDAQ |
May 17, 16:00
86.01
0.00 (0.00%)
After-Hours: 16:06
Ligand Pharmaceuticals Gross Profit (TTM): 108.64M for March 31, 2024
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
Date | Value |
---|---|
March 31, 2024 | 108.64M |
December 31, 2023 | 120.80M |
September 30, 2023 | 123.11M |
June 30, 2023 | 138.80M |
March 31, 2023 | 151.86M |
December 31, 2022 | 143.42M |
September 30, 2022 | 139.55M |
June 30, 2022 | 147.87M |
March 31, 2022 | 164.19M |
December 31, 2021 | 179.37M |
September 30, 2021 | 189.86M |
June 30, 2021 | 171.97M |
March 31, 2021 | 151.66M |
December 31, 2020 | 133.14M |
September 30, 2020 | 122.82M |
June 30, 2020 | 108.98M |
March 31, 2020 | 97.79M |
December 31, 2019 | 108.94M |
September 30, 2019 | 140.50M |
June 30, 2019 | 163.05M |
March 31, 2019 | 229.37M |
December 31, 2018 | 245.12M |
September 30, 2018 | 237.21M |
June 30, 2018 | 223.99M |
March 31, 2018 | 162.18M |
Date | Value |
---|---|
December 31, 2017 | 135.73M |
September 30, 2017 | 122.30M |
June 30, 2017 | 111.93M |
March 31, 2017 | 103.64M |
December 31, 2016 | 103.40M |
September 30, 2016 | 88.42M |
June 30, 2016 | 84.25M |
March 31, 2016 | 81.27M |
December 31, 2015 | 66.10M |
September 30, 2015 | 64.79M |
June 30, 2015 | 61.82M |
March 31, 2015 | 55.42M |
December 31, 2014 | 55.40M |
September 30, 2014 | 49.83M |
June 30, 2014 | 46.82M |
March 31, 2014 | 45.76M |
December 31, 2013 | 43.24M |
September 30, 2013 | 41.13M |
June 30, 2013 | 36.35M |
March 31, 2013 | 33.29M |
December 31, 2012 | 27.79M |
September 30, 2012 | 27.36M |
June 30, 2012 | 26.70M |
March 31, 2012 | 27.24M |
December 31, 2011 | 25.13M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (TTM) Range, Past 5 Years
97.79M
Minimum
Mar 2020
189.86M
Maximum
Sep 2021
140.32M
Average
140.03M
Median
Gross Profit (TTM) Benchmarks
ANI Pharmaceuticals Inc | 324.50M |
Annovis Bio Inc | -- |
ADMA Biologics Inc | 111.54M |
United Therapeutics Corp | 2.220B |
Blueprint Medicines Corp | 273.65M |